In our study, the 18:0 Lyso PC treatment group demonstrated regulation of adipokines by inducing a decrease in leptin and MCP-1 and an increase in adiponectin, 18:0 Lyso PC might alleviate a chronic low-inflammation due to obesity. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.